Introduction {#Sec1}
============

Respiratory diseases are among the major health problems in the pig farming industry. *Mycoplasma hyopneumoniae* is the causative agent of swine enzootic pneumonia, a chronic respiratory disease that affects herds worldwide. Although *M. hyopneumoniae* does not cause high mortality, it is considered the most expensive pathogen for swine production^[@CR1]^. This is mainly due to the costs of treatment and vaccination and to losses related to decreased animal performance. In addition, *M. hyopneumoniae* is essential for the establishment of secondary pathogens in the host, which leads to a significant increase in mortality^[@CR2]^. *M. hyopneumoniae* attaches to the cilia of the tracheal epithelial cells with participation of adhesins^[@CR3]^, resulting in ciliostasis and cell death^[@CR4]^. Besides adhesins, virulence factors are not well understood in this bacterium. Nevertheless, a recent study from our group indicated hydrogen peroxide production from glycerol and myo-inositol metabolism as important traits that might be related with pathogenesis and with the predominance of *M. hyopneumoniae* in the swine respiratory tract^[@CR5]^.

MicroRNAs (miRNAs) belong to a class of small non-coding RNAs (ncRNAs) of 18--24 nucleotides (nt) in part responsible for post-transcriptional gene regulation in eukaryotes. These evolutionarily conserved molecules influence fundamental biological processes, including cell proliferation, differentiation, apoptosis, immune response, and metabolism^[@CR6],\ [@CR7]^. The binding of miRNAs to target mRNAs changes the mRNA stability and translation efficiency^[@CR8]^, leading to degradation, suppression or up-regulation of the target mRNAs^[@CR6],\ [@CR9]^. Interactions between miRNA and mRNA are complex; one single miRNA can target a large number of genes belonging to diverse functional groups. Alternatively, the 3'-UTR of a single mRNA can be targeted by multiple miRNAs^[@CR10],\ [@CR11]^. By modulating miRNA abundance, it is thus possible to fine-tune the expression of proteins within the cell in a very precise manner^[@CR6],\ [@CR11]^.

Recently, it was widely reported that miRNAs can be packed into exosomes and transferred to neighboring or distant cells to regulate cell function^[@CR7],\ [@CR12]--[@CR14]^. Exosomes are small membrane vesicles (50--150 nm) released from eukaryotic cells both constitutively and upon induction, under normal and pathological conditions^[@CR13],\ [@CR15]^. These vesicles are involved in several cellular functions and have the potential to selectively interact with specific target cells^[@CR16],\ [@CR17]^. In addition to miRNAs, exosomes can transmit information among cells by transferring proteins, lipids and nucleic acids that seem to be selected non-randomly, with some specific populations of molecules being preferentially packaged into the vesicles^[@CR13],\ [@CR15]^. As an efficient cellular signaling and communication system, the release of exosomes by infected host cells has been recognized as a common phenomenon, in some cases beneficial to the host and in others beneficial to the pathogen^[@CR18]^.

Host-pathogen interactions result in signaling and physiological modifications in the host cells that induce differential miRNA expression and miRNA-mediated post-transcriptional regulation of genes involved in immune response and several other cellular pathways^[@CR19],\ [@CR20]^. Therefore, simultaneous identification of differentially expressed miRNAs and mRNAs provides a comprehensive view on host-pathogen interactions during the infection and the disease establishment process. In recent years, efforts have been made to identify miRNAs regulated by infection in several mammalian hosts^[@CR8],\ [@CR20]--[@CR22]^. However, the identification of miRNAs during infection of swine cells with *M. hyopneumoniae* has not been investigated so far. To improve our understanding on the *M. hyopneumoniae*-host interaction, we sequenced and analyzed both the mRNAs and miRNAs of a swine tracheal epithelial cell line infected with *M. hyopneumoniae* strain J. In addition, we identified miRNAs differentially expressed (DE) in the extracellular milieu and in exosome-like vesicles released by the infected cells, which play an important role in cell-cell communication and in the dissemination of host and pathogen-derived molecules during infection^[@CR15]^. The simultaneous identification of miRNAs and mRNAs will help us draw a full picture of the changes in gene expression and the possible regulatory mechanisms of host cells during the disease establishment.

Results and discussion {#Sec2}
======================

*M. hyopneumoniae* strain J adhered to NPTr cells {#Sec3}
-------------------------------------------------

To analyze the differential expression of New-born Pig Trachea (NPTr) cells during the infection with *M. hyopneumoniae*, we first observed the infection by immunofluorescence microscopy. These analyses were performed to detect the adherence of *M. hyopneumoniae* strain J to NPTr cells. Supplementary Figure [S1](#MOESM1){ref-type="media"} shows the co-localization of *M. hyopneumoniae* with NPTr cells, corroborating the success of the infection. As few bacteria adhered to the cells within a short period of time (1 vs. 24 h), we chose to analyze the transcriptional alterations of NPTr cells at 24 h post-infection. *M. hyopneumoniae* strain J was chosen because previous infection assays showed that highly virulent strains, such as 7448 or 7422, damaged the host cells and we were not able to recover RNA with good sequencing quality. Although this strain is considered attenuated and incapable of causing disease in vivo^[@CR23],\ [@CR24]^, our results show that *M. hyopneumoniae* is capable of adhering to the swine epithelial cells, as previously reported by Burnett et al.^[@CR25]^.

mRNA expression profiles {#Sec4}
------------------------

A total of 6 mRNA libraries were generated with the Illumina HiSeq2500 platform. A summary of the samples is provided in Table [1](#Tab1){ref-type="table"} and a diagram to explain the experimental design is given in Supplementary Fig. [S2](#MOESM1){ref-type="media"}. The raw reads were submitted to the NCBI Sequence Read Archive under accession number PRJNA545822. After removing adapters and filtering low quality reads, mRNA-seq yielded around 40 million paired-end reads in all 6 samples (approx. 97% of raw reads). Trimming and mapping information for each mRNA sample is available in Supplementary Table [S1](#MOESM2){ref-type="media"}. Around 85% of the filtered reads were mapped against the porcine genome (Sscrofa10.2---Ensembl release 89) and 40% against annotated genes (Supplementary Table [S1](#MOESM2){ref-type="media"}).Table 1Samples detailed information. The experimental design with the description of the samples is also explained in Fig. [S2](#MOESM1){ref-type="media"}.Sample IDSample nameRNA typeCompartmentConditionReplicatesmRNA 1-3mRNA CTRLmRNAIntracellularControl3mRNA 4-6mRNA INFInfected with MHPsRNA 1-3sRNA INTRA CTRLsRNAIntracellularControlsRNA 4-6sRNA INTRA INFInfected with MHPsRNA 7-8sRNA EXTRA CTRLExtracellularTotal extracellular sRNAControl2sRNA 9-10sRNA EXTRA INFInfected with MHPsRNA 11sRNA EXO CTRLsRNA from exosome-like vesiclesControlPool (50 biological replicates)sRNA 12sRNA EXO INFInfected with MHPsRNA 13sRNA SN CTRLsRNA from vesicle-free supernatantControlsRNA 14sRNA SN INFInfected with MHP

In the present study, we detected a total of 20,274 (out of 23,215) genes expressed with at least 10 counts across the 6 mRNA libraries from NPTr cells (Supplementary Table [S2](#MOESM2){ref-type="media"}). Since we used an attenuated strain of *M. hyopneumoniae* to infect the swine cells, we did not expect extreme changes in gene expression. Indeed, most of the significant log2 of Fold Changes (LogFC) of the DE genes analyzed in our results were below 1 (for up-regulated genes) or above -1 (for down-regulated genes) (Supplementary Table [S3](#MOESM2){ref-type="media"}). Nevertheless, even if the strain used (J) is considered attenuated, it generated a considerable immune response. A similar situation occurs in vaccine development, in which attenuated strains are used to generate immune response without causing lethal effects. Thus, we believe that infections with highly virulent strains of *M. hyopneumoniae* would be able to generate a more pronounced effect on gene expression than what was observed here. Regardless, our results provide a general overview of *M. hyopneumoniae* infection in the host cells.
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### M. hyopneumoniae elicited an antioxidant response and induced the accumulation of NRF2 in the nuclei of NPTr cells {#Sec5}
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Indeed, *M. hyopneumoniae* infection induced the expression of genes related to the two biggest redox systems in NPTr cells - glutathione (*GGT1, GGT5, GGLC, GSR*) and thioredoxin (*TXNRD1, PRDX5, PRDX6*) -, and also genes coding for NADPH-regenerating enzymes (used by the aforementioned redox systems), as analogously reported for activation of NRF2 targets in mice^[@CR32]^. Moreover, a number of antioxidant genes and genes coding for detoxification enzymes (such as the *AKR* gene family, *NQO1, HMOX* and *GST*) which were up-regulated during *M. hyopneumoniae* infection, were also reported to be activated by NRF2^[@CR32]^ (Table [3](#Tab3){ref-type="table"}). We performed a Fisher's exact test to compare the proportion of genes within the genome expected to be targets of NRF2 with the proportion of up-regulated genes putatively regulated by this transcription factor. The results indicate an extremely significant correlation of an NRF2 target being an upregulated gene (p-value $\documentclass[12pt]{minimal}
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                \begin{document}$$< 0.00001$$\end{document}$, Supplementary Table [S5](#MOESM2){ref-type="media"}). The up-regulation of several targets of NRF2 was further validated by reverse-transcription quantitative PCR (RT-qPCR) and the results are available in Supplementary Fig. [S3](#MOESM1){ref-type="media"}.

One of the many compounds known to activate the NRF2 pathway is hydrogen peroxide^[@CR33]^. The production of hydrogen peroxide was previously described to have an important cytotoxic effect in several *Mycoplasma* species, such as *M. pneumoniae*^[@CR34]^ and *M. mycoides* subsp. *mycoides*^[@CR35]^. More specifically, the cytotoxity of *M. mycoides* subsp. *mycoides* was correlated to the bacterium's ability to translocate hydrogen peroxide directly into the host cell^[@CR36]^. Previously, we have identified that *M. hyopneumoniae* was capable of producing this toxic product from glycerol metabolism^[@CR5]^. Although the production of hydrogen peroxide by the *M. hyopneumoniae* strain J was not detected in that work, novel analyses indicate that in conditions where glucose is scarce, the attenuated strain J is able to produce this toxic metabolite (Supplementary Fig. [S4](#MOESM1){ref-type="media"}). In addition, we were able to detect hydrogen peroxide in the medium of the NPTr cells infected with *M. hyopneumoniae* in the presence of glycerol (Supplementary Fig. [S4](#MOESM1){ref-type="media"}C). Although the production was higher in the cells infected with the pathogenic strain 7448, *M. hyopneumoniae* strain J was also able to produce the toxic product, indicating that both strains could potentially cause oxidative damage to the host cells. These results are in accordance with the gene expression of the putative enzyme responsible for hydrogen peroxide production (GlpO) in *M. hyopneumoniae* strain J, which did not differ from the pathogenic strains^[@CR5]^. During infection in general, bacteria need to compete with host cells (and other organisms in the environment) for glucose and other energy sources. For instance, in *M. pneumoniae*, Halbedel et al. (2004)^[@CR37]^ showed that even though glucose was the most efficient carbon source for biomass yield (as is the case for *M. hyopneumoniae*), the authors propose that glycerol is not only a carbon source, but it could be used by this species as an indicator that they reached their preferred ecological niche, a lipid-rich mucosal surface. Thus, it is plausible to say that *M. hyopneumoniae* also uses glycerol as a carbon source *in vivo*, however whether this is a result of competition against other fast-growing bacteria or if this species is targeting a glycerol-rich niche, we cannot affirm at this point. What we can affirm is that glycerol is not the most efficient carbon source for both *M. pneumoniae* and *M. hyopneumoniae*, and yet these species make use of it for energy uptake and also for other advantages, such as hydrogen peroxide production. Thus, it is possible that the hydrogen peroxide produced by *M. hyopneumoniae* strain J as a result of glycerol metabolism might be one of the triggers that activated the transcription factor NRF2.

It has been demonstrated in other species that NRF2 is largely regulated at the post-transcriptional level by its sub-cellular distribution, which is controlled by the Kelch-like ECH-associated protein (KEAP1). Under normal conditions, a portion of NRF2 is retained in the cytoplasm via its interaction to KEAP1 and it is subsequently ubiquitinated and degraded by the proteasome. In response to oxidative stress, reactive cysteines in KEAP1 are modified, generating conformational changes in the complex and releasing NRF2, which is translocated and accumulates into the nucleus^[@CR27],\ [@CR32],\ [@CR38]^. In our analysis, we did not detect a difference in the expression of the mRNAs of NRF2 (base mean expression around 8000 reads, a logFC between infected and non-infected conditions close to zero and a non-significant adjusted p-value of 0.99) and KEAP1 (base mean expression around 4500 reads, logFC between infected and non-infected conditions close to zero and non-significant adjusted p-value of 0.94). However, we were able to demonstrate by confocal immunofluorescence microscopy (Fig. [2](#Fig2){ref-type="fig"}) that both the attenuated and the virulent strains of *M. hyopneumoniae* induced a statistically significant accumulation of this transcription factor in the nuclei of NPTr cells (Fig. [2](#Fig2){ref-type="fig"}B). In the nucleus, NRF2 is able to recognize and bind to antioxidant response element (ARE) motifs in the promoter region of target genes, activating their transcription^[@CR39]^. In this work, we detected at least one conserved ARE sequence upstream the start codon in the promoter regions of 44 out of the 46 NRF2 predicted targets (with stringent search to TG/TAnnnnGC) with the use of fuzznuc software from EMBOSSv6.6.0 package^[@CR40]^ (Supplementary Table [S6](#MOESM2){ref-type="media"}).Figure 2Localization and expression pattern of the NRF2 protein in cells infected with *M. hyopneumoniae.***A.** Results of the immunofluorescence microscopy analysis indicating the accumulation of NRF2 in the nuclei of infected cells after 1 h of incubation. Both attenuated (J) and virulent (7448) strains of *M. hyopneumoniae* induced the accumulation of the transcription factor in the nuclei of the epithelial cells. Eukaryotic cell NRF2 was labeled with anti-NRF2 antibody (green) and nuclei were stained with DAPI (blue). Scale bars: $\documentclass[12pt]{minimal}
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                \begin{document}$$50\,\mu \hbox {m}$$\end{document}$. **B.** Total NRF2 green fluorescence per nucleus of control and infected cells. Both *M. hyopneumoniae* strains significantly increased the concentration of NRF2 in the nuclei of infected cells. Boxplots represent the measures of at least 25 nuclei in each condition. Outliers are represented as black dots. CTCF---corrected total cell fluorescence. NPTr - uninfected cells. MHP J - NPTr cells infected with *M. hyopneumoniae* strain J. MHP 7448 - NPTr cells infected with *M. hyopneumoniae* strain 7448. \*\*\*\* $\documentclass[12pt]{minimal}
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In this way, it seems that *M. hyopneumoniae* infection has the potential to cause oxidative stress to the host cells, which in turn activate antioxidant response genes induced by NRF2 to fight the infection and maintain cellular homeostasis. We believe that this oxidative stress was in part related to the hydrogen peroxide produced by this bacterium, although more experiments are needed to prove the association between this mechanism and the up-regulation of antioxidant response genes.

### M. hyopneumoniae induced down-regulation of cytoskeleton and ciliary genes as well as a decrease of actin stress fibers in NPTr cells {#Sec6}

We identified several down-regulated genes related to ciliary function, cytoskeleton and cell cycle/cell division. The impairment of the ciliary motility is a well-known effect caused by several *Mycoplasma* respiratory species^[@CR41]^, such as *M. pneumoniae* and *M. gallisepticum*^[@CR42],\ [@CR43]^. It is also well established that *M. hyopneumoniae* attaches to cilia of epithelial cells and promotes ciliostasis and loss of cilia, causing damage to the mucociliary apparatus^[@CR4],\ [@CR24]^. Therefore, our hypothesis is that one of the reasons for epithelial damage, besides physical adhesion, could be associated with modulations in gene expression induced by the infection, which is a running hypothesis for at least two epithelial pathogens from the genus *Mycobacterium*^[@CR44]^. In agreement with this hypothesis, we were able to identify the down-regulation of genes coding for axonemal dyneins (*DNAH11, DNAH12, DNAI2, DNAL1*), which are essential for the ciliary motility^[@CR45]^. In addition, genes necessary for axonemal dynein assembly (*DYX1C1*)^[@CR46]^, genes related to ciliogenesis (*CEP162, DCDC2, MACF1, IFT57*)^[@CR47]--[@CR50]^, ciliary polarization (*INTU*)^[@CR51]^, ciliary beating (*MYO1D*)^[@CR52]^ and several others in which the mutation or knockout is associated with ciliopathies (*LRRC6, MNS1, AK7*)^[@CR53]--[@CR55]^ were down-regulated in the infected cells (Table [4](#Tab4){ref-type="table"}). Interestingly, in line with our results, a recent study compared the transcriptional response of unvaccinated and vaccinated chicken infected with *M. gallisepticum* and the authors identified enrichment of GO terms in down-regulated genes related to cilia and cytoskeleton in unvaccinated animals^[@CR56]^. Protein functions encoded by the top down-regulated genes were involved in microtubule assembly and stability, axonemal dynein complex assembly, and formation and motor movement of cilia, indicating that at least in one *Mycoplasma* species the ciliary damage caused by infection could be also explained by the down-regulation of genes involved in the ciliary function.Table 4Down-regulated genes involved in cytoskeleton and cilia.DE genesDESeq2EdgeRGene IDAssociated gene nameDescriptionLogFCP-adjLogFCP-adjENSSSCG00000011441*TNNC1*Troponin C1, Slow Skeletal And Cardiac Type$\documentclass[12pt]{minimal}
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Besides ciliary genes, we also detected the down-regulation of cytoskeleton-related genes, both from microtubules and actin filaments, involved in the organization, rearrangement and stability of these structures (Table [4](#Tab4){ref-type="table"}). It was previously described that the intracellular species *M. penetrans* is able to trigger reorganization of the host cell cystoskeleton, promoting aggregation of tubulin and $\documentclass[12pt]{minimal}
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                \begin{document}$$\alpha $$\end{document}$-actinin and condensation of phosphorylated proteins^[@CR57]^. To investigate if *M. hyopneumoniae* indeed affected the host cell cytoskeleton, we verified the organization of actin fibers in infected cells by confocal immunofluorescence microscopy. The actin stress fibers were notably less evident in the infected cells, as opposed to the control condition, in which they were abundant and more evenly distributed (Fig. [3](#Fig3){ref-type="fig"}). However, whenever present in the infected conditions, these stress fibers were either disorganized and/or at the periphery of the cells. These results corroborate studies from Raymond et al. (2018)^[@CR58]^, which suggested that this species induces cytoskeletal rearrangements in the porcine respiratory tract. Although actin is not a major component of the ciliary axoneme, actin cytoskeleton has been implicated in every stage of ciliogenesis and many aspects of ciliary function^[@CR59]^, directly associating these two down-regulated functions. In addition, it has recently been shown that *M. hyopneumoniae* expresses surface-accessible actin-binding proteins and that the host's extracellular actin may act as a receptor for this bacterium in PK-15 epithelial cells^[@CR60]^, indicating its importance for successful infection. Furthermore, the reduction of visible actin stress fibers caused by *M. hyopneumoniae* may also be related to the activation of NRF2, since the actin cytoskeleton is a scaffold necessary to maintain the transcription factor in the cytoplasm^[@CR61]^.Figure 3Organization of actin fibers in cells infected with *M. hyopneumoniae.* Results of the immunofluorescence microscopy analysis indicating the reduction and change in the pattern of actin stress fibers in infected cells. Eukaryotic cell actin was labeled with phalloidin (red) and nuclei were stained with DAPI (blue). Both attenuated (J) and virulent (7448) strains of *M. hyopneumoniae* altered the organization and abundance of actin fibers after 24 h of infection, however this effect can already be seen after 1 h of incubation (not shown). NPTr - uninfected cells. MHP J - NPTr cells infected with *M. hyopneumoniae* strain J. MHP 7448 - NPTr cells infected with *M. hyopneumoniae* strain 7448. Scale bars: $\documentclass[12pt]{minimal}
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We also identified the down-regulation of cytoskeleton-related genes that play a role during cell division, such as *BUB1B, CENP-I, NEK2* and *SPAG5* (Supplementary Table [S3](#MOESM2){ref-type="media"}). Many of these genes are involved with the mitotic spindle and chromosome segregation^[@CR62]--[@CR69]^. Genes encoding microtubule dependent motor proteins that physically affect chromosome segregation, such as kinesins (usually up-regulated during mitosis)^[@CR70]^, as well as genes related to cell cycle progression were down-regulated during infection (Supplementary Table [S3](#MOESM2){ref-type="media"}). These results suggest a repression of cell division of infected cells. The manipulation of cell cycle by pathogens has been extensively reported, with different pathogens being able to arrest different points of the cell cycle^[@CR71]--[@CR74]^. Therefore, it is possible that *M. hyopneumoniae* infection also interferes with the host cell cycle.

miRNA expression profiles {#Sec7}
-------------------------

A total of 14 small RNA (sRNA) libraries were generated with the Illumina HiSeq2500 platform (Supplementary Table [S7](#MOESM2){ref-type="media"}). A complete description of the samples is provided in Table [1](#Tab1){ref-type="table"} and Fig. [S2](#MOESM1){ref-type="media"}. The raw reads were submitted to the NCBI Sequence Read Archive under accession number PRJNA545822. After removing adapters and filtering low quality reads, sRNA-seq yielded from 1 to 21 million single-end clean reads. Trimming and mapping information for each sRNA sample is given in Supplementary Table [S7](#MOESM2){ref-type="media"}.

For intracellular sRNAs (INTRA: samples S1 to S6), we were able to map around 93% of the reads against the porcine genome. We also mapped all sRNA reads against the *M. hyopneumoniae* strain 7448 genome and samples had no more than 0.05% of unique mycoplasmal reads (Supplementary Table [S7](#MOESM2){ref-type="media"}). All intracellular sRNA samples had similar sequencing depth and showed a typical miRNA distribution length curve ranging from 18 to 26 nt, with a peak at 22 nt (Supplementary Fig. [S5](#MOESM1){ref-type="media"}A). We also performed a homology analysis of raw reads and we provide the percentage of intracellular clean reads clustered by classical types of sRNAs (Supplementary Fig. [S5](#MOESM1){ref-type="media"}B), showing an enrichment of miRNA-homolog reads (around 40%).

As expected, total extracellular sRNA samples (EXTRA: S7 to S10) had more RNA degradation due to the presence of RNAses and degraded mRNAs in the extracellular environment. Extracellular sRNA samples of cells infected with the bacterium (S9 and S10) had up to 20% of reads mapped to *M. hyopneumoniae*, as they were presumed to have more remnants of mycoplasmal cells (Supplementary Table [S7](#MOESM2){ref-type="media"}). However, the great majority of reads mapping to the bacteria were mainly product of mRNA degradation, as they did not have any specific signature for sRNAs when compared to previous results from Siqueira et al. (2016)^[@CR75]^. In this way, we filtered out (i) sequences $\documentclass[12pt]{minimal}
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                \begin{document}$$< 18$$\end{document}$ nt and (ii) sequences mapped to the *M. hyopneumoniae* genome. Sample S8 (EXTRA) had a sequencing depth smaller than its replicate (S7); however, the distribution of counts was overall similar between replicates and we included it in the further analyses.

Extracellular exosomal sRNA samples (EXO: S11 and S12) had some RNA degradation ($\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$<18$$\end{document}$ nt), but maintained a pronounced peak at 22 nt. Extracellular sRNAs from vesicle-free supernatant (SN: samples S13 and S14) were more problematic, probably due to (i) too many pre-processing steps and (ii) the presence of RNAses in the extracellular environment. Sample S14 did not yield a minimum amount of reads necessary for the subsequent steps and this condition (SN) was not used for further analyses.

### Annotation of known and novel miRNAs {#Sec8}

In order to perform miRNA prediction with mirDeep2^[@CR76]^, we only took into account reads from intracellular samples. We predicted a total of 1,041 miRNAs, which were further clustered into 773 groups. From these, 478 were completely novel (Supplementary Table [S8](#MOESM2){ref-type="media"}). We created a *Sus scrofa* miRNA database (ssc-miRNA-DB) with 1,906 different entries from three different sources: 411 known miRNAs in *Sus scrofa* from miRBase (release 21)^[@CR77]^, 722 annotated by Martini et al., (2014)^[@CR78]^ and the 773 clusters of mature miRNAs predicted by our analysis. More than 50% of intracellular sRNA clean reads were aligned against the ssc-miRNA-DB (Supplementary Table [S7](#MOESM2){ref-type="media"}). All other samples were also mapped against this database. The complete pipeline used in this study for miRNA prediction is described in Supplementary Fig. [S6](#MOESM1){ref-type="media"}.

### miRNA differential expression {#Sec9}

In all sRNA samples, we detected (with at least 10 counts across all libraries) 290 from the 411 miRNAs from miRBase and 214 of the miRNAs described by Martini et al., (2014)^[@CR78]^. Also, 263 predicted miRNAs had more than 10 counts across all libraries. We only took into account the 491 miRNAs that had more than 50 counts across all libraries for differential expression analysis (Supplementary Table [S9](#MOESM2){ref-type="media"}).

In total, we identified 170 DE miRNAs (121 up-regulated, 48 down-regulated and 1 ambiguous). Table  [5](#Tab5){ref-type="table"} shows 10 selected up-regulated and down-regulated miRNAs detected in this study, and the complete list of DE miRNAs is summarized in Supplementary Table [S10](#MOESM2){ref-type="media"}. Several homologs of these miRNAs have already been linked to bacterial infection response or immune system response in the literature and these references are listed in Table [5](#Tab5){ref-type="table"}. With the exception of one ambiguous case (ssc-miR-9842-5p), whenever a miRNA was detected as DE in more than one condition (INTRA, EXTRA or EXO), the change in expression (either up- or down-regulated) was in accordance between them (Supplementary Table [S10](#MOESM2){ref-type="media"}).Table 5Selected DE miRNAs. Information about selected up- and down-regulated miRNAs in intracellular, extracellular and exosome samples.miRNA IDDB TypeIntracellularExtracellularExosomesPlay a role in other bacterial infectionDELogFCDELogFCDEGFOLDNovel-Chr13-miR-10novelUpregulated4.121$\documentclass[12pt]{minimal}
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### Targets of DE miRNAs were enriched in genes related to redox homeostasis, translation and cytoskeleton {#Sec10}

In order to better understand the biological functions that could be involved with the 170 DE miRNAs, we performed different analyses to predict their potential targets. In this sense, all DE miRNAs had at least one DE gene as a predicted target. The complete pipeline used for target prediction in this study is provided in Supplementary Fig. [S7](#MOESM1){ref-type="media"}.

We predicted a total of 79,276 interaction pairs between miRNAs and mRNAs. In this way, based only on the predictions of the software used here, a miRNA could potentially target, on average, 465 genes in the entire porcine genome. However, we only considered as targets the mRNAs that were detected as DE in this study, which significantly decreased our list to a total of 4,287 interaction pairs. We chose to focus on anticorrelations between miRNA and mRNA expression (and kept 1,939 interaction pairs), as the main mode of action of miRNAs is a destabilization of mRNAs^[@CR79]^ and the fact that most of experimental validations in the literature are related to interaction pairs with inversed regulation. In this context, a permissive interaction is generally described as one that occurs between a down-regulated miRNA and an up-regulated mRNA, while a repressive interaction is one in which the miRNA is up-regulated with consequent down-regulation of the target mRNA^[@CR78]^ (Fig. [4](#Fig4){ref-type="fig"}A). In our results, permissive interactions represented 267 genes and 50 miRNAs, while repressive interactions occurred between 425 genes and 121 miRNAs, accounting for 598 permissive and 1341 repressive interactions between DE mRNAs and miRNAs. Supplementary Table [S11](#MOESM2){ref-type="media"} summarizes the permissive and repressive target pairs predicted in this study.Figure 4Correlation of GO terms between DE mRNAs and targets of DE miRNAs. **A** A permissive interaction occurs between a down-regulated miRNA (depicted in blue) and an up-regulated mRNA (depicted in red), whereas a repressive interaction is one in which the miRNA is up-regulated (red) and its target mRNA is down-regulated (blue). **B.** We performed GO enrichment analyses with the complete up- and down-regulated lists of mRNAs and also with the subset of miRNA targets among each of these lists. **C.** A correlation of some of the GO terms from DE mRNAs and targets of DE miRNAs was detected, indicating that these functions might also be regulated by miRNAs.

We performed GO analyses to compare the DE genes and targets of DE miRNAs in order to investigate whether their functions could be correlated (Fig. [4](#Fig4){ref-type="fig"}B and Supplementary Fig. [S8](#MOESM1){ref-type="media"}). Interestingly, we were able to identify a correlation between the enriched terms in miRNA targets with some of the GO terms detected in the mRNA up-regulated or down-regulated GO results (Fig. [4](#Fig4){ref-type="fig"}C). Target genes from permissive interactions were associated with ribosome/translation and oxidation-reduction activity, whereas target genes from the repressive interactions had enriched terms related to cytoskeleton and ciliary function (Fig. [4](#Fig4){ref-type="fig"}C). It is important to highlight the relevance of the miRNAs found in exosome-like vesicles and in extracellular samples in the identification of GO enriched terms of the miRNA targets, since only a small part of the permissive and repressive interactions involved intracellular miRNAs. Complete GO enrichemnt of the miRNA targets is found in Supplementary Table [S12](#MOESM2){ref-type="media"}.

### Regulatory network reconstruction and analysis {#Sec11}

In order to gain a broader view of the host's response to the presence of *M. hyopneumoniae*, we built a general regulatory network by integrating mRNA gene expression with predicted miRNA-mRNA interactions collected and analyzed in this work (Supplementary Fig. [S9](#MOESM1){ref-type="media"}). We also included information about physical and genetic validated interactions from the BioGRID v3.4 database^[@CR80],\ [@CR81]^. As previously mentioned, at this point we only took into account interaction pairs that were either repressive or permissive. The global interaction network was composed by 774 nodes and 1965 arcs and our objective was to identify miRNA-mRNA expression patterns. We performed a functional analysis with the use of CLueGO^[@CR82]^ and we also detected within the permissive interactions the enrichment of several processes related to immune response and inflammation (Supplementary Fig. [S10](#MOESM1){ref-type="media"}).Figure 5Interaction networks of DE miRNAs and genes involved with cytoskeleton/cilia and redox homeostasis. Rectangles depict miRNAs and ellipses represent genes. Blue ellipses/rectangles indicate that the gene/miRNA was down-regulated and red indicate gene/miRNAs detected as up-regulated. BioGrid interactions are seen as green dashed arcs. These represent both physical and genetic interactions between either genes or proteins from such genes. **A.** Cytoskeleton/cilia interaction network. We detected many repressive interactions involving genes related to cytoskeleton and ciliary function (blue arcs). **B.** Redox homeostasis interaction network. Permissive interactions of genes related to redox homeostasis are shown as red arcs. The great majority of the miRNAs targeting these genes are DE only in exosomes (rectangles partially colored in blue, far right). NRF2 targets: genes described in other species to be activated by NRF2 are highlighted in grey.

Furthermore, we created two separate regulatory networks, one related to cytoskeleton and cilia (repressive interactions, Fig. [5](#Fig5){ref-type="fig"}A) and one related to redox homeostasis (permissive interactions, Fig. [5](#Fig5){ref-type="fig"}B) to better refine and understand the possible co-regulation of several of these targets. The networks show a high level of connectivity and we were able to detect miRNAs that interacted only with NRF2 activated targets (such as ssc-miR-31) (Table [6](#Tab6){ref-type="table"}). Furthermore, we were able to detect miRNAs that seemed to regulate more generally redox homeostasis genes and also miRNAs whose targets came from sets of genes with distinct functions (such as glycolysis, immune system defense, ribosomes, among others), indicating that this response might be related to several other important functions within the cell. We believe that this network can be a powerful tool for analyzing the influence of *M. hyopneumoniae* on the host gene expression in future studies.Table 6DE genes putatively activated by NRF2 predicted to be targets of DE miRNAs. Expression of miRNAs is reported for intracellular, extracellular and exosome-like vesicles. NS: Not significant; ND: Not detected.Upregulated gene IDDownregulated miRNAmiRNA expressionIntracellularExtracellularExosome*AKR1C1*ssc-miR-101NSDownregulatedDownregulated*AKR1C4*ssc-miR-31NSDownregulatedDownregulated*AKR1CL1*ssc-miR-31NSDownregulatedDownregulated*BLVRB*prediction_13_40037950_40038026\_-\_3p-353-MCNSNDDownregulated*EGR1*antisense-ssc-mir-423_12_44150500_44150579\_-\_NA-353-MCNSNSDownregulated*GCLC*ssc-miR-148b-3pNSNSDownregulatedssc-miR-19aNSNSDownregulatedssc-miR-19bNSNSDownregulated*GGT1*ssc-miR-338NSNDDownregulatedssc-miR-140-3pNSNSDownregulatedssc-mir-92-shorter/ssc-isomir-92_X\_108178486_108178565\_-\_NA;ssc-mir-92-shorter/ssc-isomir-92_X\_108212408_108212487\_-\_NA-424-HCNSNSDownregulatedssc-miR-92aNSNSDownregulatedprediction_7\_91732076_91732132\_+\_5p-353-MCNSNSDownregulatedssc-miR-31NSDownregulatedDownregulatedantisense-pn8/bta-mir-2320_6\_43886629_43886722\_-\_NA-424-HCNSDownregulatedDownregulated*GSR*ssc-miR-101NSDownregulatedDownregulatedssc-miR-22-3pNSNSDownregulated*HMOX1*ssc-miR-182NSNSDownregulated*HSP90AB1*ssc-miR-101NSDownregulatedDownregulated*NQO1*ssc-miR-34aNSNSDownregulated*PGD*ssc-miR-769-3pNSDownregulatedNS*PIR*ssc-miR-378NSNSDownregulated*PRDX1*ssc-miR-101NSDownregulatedDownregulated*PRDX6*ssc-miR-10a-5pNSNSDownregulatedssc-miR-10bNSNSDownregulatedssc-miR-338NSNDDownregulated*SLC5A10*ssc-miR-1307NSNDDownregulatedantisense-pn8/bta-mir-2320_6\_43886629_43886722\_-\_NA-424-HCNSDownregulatedDownregulated*SLC5A6*ssc-miR-10bNSNSDownregulatedssc-miR-338NSNDDownregulatedssc-miR-423-3pNSNDDownregulatedssc-miR-27b-3pNSNSDownregulatedprediction_7\_91732076_91732132\_+\_5p-353-MCNSNSDownregulatedssc-miR-340NSNDDownregulated*SOD2*prediction_7\_91732076_91732132\_+\_5p-353-MCNSNSDownregulatedssc-miR-184DownregulatedNDNDssc-miR-28-3pNSNSDownregulated*TKT*antisense-ssc-mir-423_12_44150500_44150579\_-\_NA-353-MCNSNSDownregulated*TXNRD1*ssc-miR-103NSNSDownregulatedssc-miR-182NSNSDownregulatedssc-mir-107-shorter/ssc-isomir-107_14_106321702_106321788\_-\_NA-424-HCNSDownregulatedDownregulatedssc-miR-107NSDownregulatedDownregulatedssc-miR-31NSDownregulatedDownregulated*UGT1A6*ssc-miR-28-3pNSNSDownregulatedantisense-ssc-mir-103_16_52667657_52667738\_+\_NA-424-HCNSNSDownregulatedssc-miR-769-3pNSDownregulatedNS

### Permissive interactions were enriched in genes regulated by NRF2 {#Sec12}

Analyzing more in detail the permissive interactions between mRNAs and miRNAs, we identified several miRNAs targeting NRF2 regulated genes (Table [6](#Tab6){ref-type="table"}). *GGT1*, for instance, is predicted to be targeted by 7 different miRNAs, while ssc-mir-31 is predicted to target 4 different genes induced by NRF2 (*AKR1C4, AKR1CL1, GGT1*, and *TXNRD1*).

It was previously reported that *NRF2* can be regulated independently of KEAP1 by miRNAs in human breast cancer cells^[@CR83]^. Our miRNA target analysis predicted *NRF2* as target of three miRNAs down-regulated in exosome-like vesicles: ssc-mir-340, ssc-mir-19a, and ssc-mir-19b. The first was also predicted to target the transporter gene *SLC6A6*, while ssc-mir-19a and ssc-mir-19b were predicted to target *GCLC*, necessary for glutathione synthesis. In addition, miR-340 has been previously identified negatively regulating *NRF2* expression in human^[@CR84]^. Conversely, miR-19a and miR-19b have been reported to be down-regulated in the presence of hydrogen peroxide in rats^[@CR85],\ [@CR86]^, linking these miRNAs to a response to oxidative stress.

In the literature, other miRNAs were also shown to negatively regulate the expression of *NRF2*: miR-28^[@CR83]^, miR-101^[@CR87]^, miR-92a^[@CR88]^, miR-27b^[@CR89]^, and miR-34a^[@CR90]^. All of them were down-regulated in our data and were predicted by this study to regulate NRF2 activated genes (Table [6](#Tab6){ref-type="table"}). In this way, it seems that during *M. hyopneumoniae* infection, there is a global change in gene expression in an attempt to activate antioxidant genes, in association with the down-regulation of miRNAs that negatively regulate these genes.

### Repressive interactions were related to cytoskeleton and cilia {#Sec13}

As concerns the repressive interactions of miRNAs and mRNAs, we identified within the targets of up-regulated miRNAs an enrichment of genes related to cytoskeleton and cilia (Supplementary Table [S11](#MOESM2){ref-type="media"}). For instance, the gene *TNS3*, related to cytoskeleton, is predicted as target of 16 up-regulated miRNAs (Supplementary Table [S11](#MOESM2){ref-type="media"}). In addition, several genes encoding for dyneins were predicted as targets of up-regulated miRNAs, with *DNAL1* being target of 7 different miRNAs. Mutations and down-regulation of genes coding ciliary proteins, especially dyneins, were related to primary ciliary dyskinesia^[@CR46],\ [@CR48],\ [@CR53],\ [@CR55],\ [@CR91]^, but had not yet been reported in *M. hyopneumoniae* infection. More investigations on this matter should be carried out, since these results seem to be related to one of the main adverse effects caused by this bacterium: ciliostasis.

### Most DE miRNAs were detected in exosome-like vesicles {#Sec14}

Analyzing the up-regulated genes, we identified that besides antioxidant response and protein synthesis, there is an enrichment in GO terms related to cell-cell communication (Fig. [1](#Fig1){ref-type="fig"}). The up-regulation of cell-cell communication is noteworthy considering that most DE miRNAs were detected only in the extracellular and exosome-like samples (Supplementary Table [S10](#MOESM2){ref-type="media"}). Moreover, most of the down-regulated miRNAs of exosome-like vesicles were DE only in these vesicles, indicating that the cells might be selecting specific populations of miRNAs to be packaged into these structures, which could be seen as a specific message they are trying to communicate to other cells. In the same direction, the increase in the number of proteins secreted in vesicles was reported in NPTr cells infected with *M. hyopneumoniae*^[@CR92]^, indicating that the communication via exosome-like vesicles is important for swine cells during infection. This corroborates our data, suggesting that *M. hyopneumoniae* induces modification on the protein and RNA composition of NPTr-released vesicles and is likely important in the cross-talks between epithelial cells.

The relationship between cell--cell communication and DE miRNAs released by infected cells becomes especially interesting when considering genes related to the NRF2 pathway: we identified DE miRNAs predicted to regulate such genes only in extracellular and exosome-like vesicle samples, with no difference of expression in intracellular samples (Table [6](#Tab6){ref-type="table"}). This might suggest the existence of a mechanism in which infected cells send signals to neighboring cells in order to prevent the repression of these genes or degradation of their RNA products. This becomes even more important due to the fact that exosomal miRNAs were already shown to regulate the inflammatory response in receptor cells from mice^[@CR93]^. While miRNAs identified in the extracellular total samples might contain sRNAs that reflect degradation remnants due to the presence of RNAses and mRNAs in the extracellular environment, we believe that this is less likely to happen in exosomes, since these vesicles have a membrane that protects their content from extracellular degradation. As exosomes have an important role in cell communication, we should consider the difference in miRNA expression in these vesicles as relevant and speculate on how they might interfere in the gene regulation of neighboring cells. In addition, as exosomes may also affect other cell types, they may contain miRNAs that target genes that were not detected as DE in our samples.

Concluding remarks {#Sec15}
==================

*M. hyopneumoniae* is considered a pathogen with huge negative impact on swine production. However, apart from studies related to adherence to the host cells, little is known about the relationship between this pathogen and the swine host. In this work, we analyzed the changes that *M. hyopneumoniae* induced in gene and miRNA expression in tracheal epithelial cells. As far as we know, this is the first study to establish a link between gene expression of the swine cells and the most deleterious pathogenic effects of *M. hyopneumoniae*, namely its cytotoxic epithelial damage (possibly via hydrogen peroxide production) and induced ciliostasis. However, we are aware that infection with this species involves a large component of the immune system, which is even said to be responsible for the major tissue damage related to the infection. Thus, the results found here reflect the effects of *M. hyopneumoniae* on epithelial cells, while the general picture of the respiratory tract might present different responses to the infection. In this way, it is important to observe that besides the hydrogen peroxide production by this bacterium, other factors can trigger the activation of the cell antioxidant defense during infection. *M. hyopneumoniae* infection is characterized by the infiltration of a large number of leukocytes in the lung tissue, which produce reactive oxygen and nitrogen species, causing tissue damage^[@CR38],\ [@CR94]^. Accordingly, systemic infections with *M. hyopneumoniae* have a great potential of causing oxidative stress, so that the transcription of genes activated by NRF2 seems to be important to fight the infection and maintain cellular homeostasis.

In conclusion, we conducted the first study that analyzes mRNA and miRNA differential expression by NGS in epithelial tracheal cells infected with *M. hyopneumoniae*. Our results bring new insights into the interaction between this bacterium and swine epithelial cells, notably the host cellular response through the activation of genes related to antioxidant response and the repression of cytoskeleton and ciliary genes (possibly related to ciliostasis), and open several perspectives related to the understanding of the pathogenicity of this bacterial species.

Methods {#Sec16}
=======

Cultivation of NPTr cells {#Sec17}
-------------------------

NPTr cells^[@CR95]^ negatively tested for mycoplasma, purchased from Instituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Brescia, Italy, were grown in Minimum Essential Medium with Earle's Balanced Salts (MEM/EBSS) and 2 mM L-Glutamine (GE Healthcare) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS) (Gibco) and 1% penicillin streptomycin (GE Healthcare). Cells were cultured at $\documentclass[12pt]{minimal}
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                \begin{document}$$cm^{2}$$\end{document}$ flasks and 6-well tissue culture plates. Sub-passages were made when cells reached 70-80% confluence. To isolate exosome-like vesicles, the culture medium was removed, confluent cells were washed with phosphate-buffered saline (PBS) and kept in medium without FBS and antibiotics (exosome depleted) for 24 h.

Infection of NPTr cells with *M. hyopneumoniae* {#Sec18}
-----------------------------------------------

*Mycoplasma hyopneumoniae* strain J (ATCC25934) was cultivated in Friis medium^[@CR96]^ at $\documentclass[12pt]{minimal}
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                \begin{document}$$37\,{^{\circ }}\hbox {C}$$\end{document}$ for 48 h with gentle agitation in a roller drum. Prior to NPTr infection, *Mycoplasma* cells were pelleted, washed with PBS and resuspended in MEM/EBSS medium. Based on the methodology described by Assunção et al. (2005)^[@CR97]^, we calculated an MOI of 5 *M. hyopneumoniae* for the immunofluorescence experiments and an MOI of 2 for the RNA extraction experiments. NPTr cells were challenged with *M. hyopneumoniae* for 24 h.

Immunofluorescence microscopy {#Sec19}
-----------------------------

NPTr cells were grown in cover slips coated with poly-L-lysine (Sigma-Aldrich) for 48 h and infected (or not, in the control conditions) with *M. hyopneumoniae* for 24 h or 1 h in the case of the NFR2 localization experiment. The cells were washed with 1x PBS three times and fixed with 4% paraformaldehyde for 15 min. After permeabilization with 0.2% Triton X-100 for 10 min and blocking with 4% BSA in PBS for 20 min, the cells were incubated with the primary antibodies (rabbit polyclonal anti-SPAse I of *M. hyopneumoniae*^[@CR98]^, 1:10,000, and mouse monoclonal anti-Sodium/Potassium ATPase alpha (Invitrogen), 1:20, or rabbit polyclonal anti-NRF2 (Thermo Fisher Scientific), 1:200,) overnight at $\documentclass[12pt]{minimal}
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                \begin{document}$$4\,{^{\circ }}\hbox {C}$$\end{document}$ followed by secondary antibodies (Alexa Fluor488-conjugated anti-rabbit (Invitrogen), 1:1,000, and Alexa Fluor555-conjugated anti-mouse (Invitrogen), 1:1,000) incubation for 1 h in the dark. The cells were washed with PBS and the DNA was stained with 100 nM DAPI and actin was marked with 50 nM phalloidin for 20 min. The slides were mounted with Fluoromount (Sigma-Aldrich). Samples were imaged using an Olympus FluoView 1000 confocal microscope. NRF2 fluorescence was quantified by drawing margin to each individual nucleus and measuring the green fluorescence against the cell background. At least 25 nuclei were quantified in each condition with the ImageJ software^[@CR99]^. The Corrected Total Fluorescence (CTCF) of each nucleus was calculated with the following formula: CTCF = Integrated density -- (Area of the selected nucleus x fluorescence of the background reading). Statistical significance was analyzed by One-way ANOVA followed by Dunnett's multiple comparison test ($\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {p} < 0.05$$\end{document}$) in GraphPad Prism 7.0 software.

Exosome extraction {#Sec20}
------------------

Exosome-like vesicles were purified from 250 mL (25 F75 $\documentclass[12pt]{minimal}
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                \begin{document}$$cm^{2}$$\end{document}$ flasks) of NPTr conditioned medium (as described by Forterre et al.^[@CR17]^). Briefly, after 24 hours of incubation, the medium was recovered and cell debris and organelles were eliminated by centrifugation at 2,000 x g for 20 min and at 10,000 x g for 30 min. The resulting supernatant was filtered through a $\documentclass[12pt]{minimal}
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                \begin{document}$$0.22\,\mu \hbox {m}$$\end{document}$ filter in order to remove large particles. Exosome-like vesicles were pelleted by ultracentrifugation at 100,000 x g for 90 min $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$4\,{^{\circ }}\hbox {C}$$\end{document}$ (Beckman-Coulter, Optima MAX-XP ultracentrifuge, MLA-55 rotor). The supernatant was recovered and saved for posterior use (SN) and the exosome sediment was washed with 25 mL of cold PBS, centrifuged at 100,000 x g for 70 min $\documentclass[12pt]{minimal}
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                \begin{document}$$50\,\mu \hbox {L}$$\end{document}$ PBS. Vesicle extractions were performed in duplicates in both conditions of NPTr cells non-infected and infected with *M. hyopneumoniae*. SN portion was submitted to nucleic acid precipitation with 1/10 volume of 3 M sodium acetate and 3 volumes of 100% cold ethanol at $\documentclass[12pt]{minimal}
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                \begin{document}$$-20\,{^{\circ }}\hbox {C}$$\end{document}$ overnight. After centrifugation, the nucleic acid precipitated was allowed to dry at $\documentclass[12pt]{minimal}
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                \begin{document}$$60\,{^{\circ }}\hbox {C}$$\end{document}$ for 1 hour and was ressuspended in $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$100\,\mu \hbox {L}$$\end{document}$ of ultrapure RNAse free water.

Sample preparation, RNA extraction and sequencing {#Sec21}
-------------------------------------------------

For mRNA sequencing, a total of 6 samples were prepared: 3 in a control group (CTL) and 3 in the infected group (INF). For miRNA sequencing, we prepared the samples as follows: total intracellular miRNA (INTRA: 3 CTL vs 3 INF), total extracellular small RNA (EXTRA: 2 CTL vs 2 INF), extracellular exosomal miRNA (EXO: 1 pool CTL vs 1 pool INF) and extracellular miRNA from vesicle-free supernatant (SN: 1 pool CTL vs 1 pool INF: a single library was constructed from a pool of 50 biological replicates). Total RNA for mRNA sequencing and sRNA enriched ($\documentclass[12pt]{minimal}
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                \begin{document}$$< 200$$\end{document}$bp) for sRNA sequencing and miRNA analyses were extracted with mirVana kit (Ambion), according to the manufacturer's instructions. Total extracellular RNA for sRNA sequencing was directly extracted from the culture NPTr cell supernatant after centrifugation of cell debris. Exosome sRNA was extracted after vesicle purification. RNA quality was assessed with Bioanalyzer 2100 (Agilent Genomics). A total of 6 mRNA libraries were prepared (one for each sample) using TruSeq Stranded Total RNA Sample Preparation kit (Illumina) and a total of 14 small RNA libraries were prepared using TruSeq Small RNA Sample Prep kit (Illumina). After quality control, the sequencing of all libraries was performed by HiSeq2500 platform (Illumina). RNA library preparation and sequencing was performed by the Duke University GCB Sequencing Platform (Durham, USA).

RT-qPCR of selected differentially expressed mRNAs {#Sec22}
--------------------------------------------------

For RT-qPCR, total RNA of NPTr cells infected and non-infected with *M. hyopneumoniae* was isolated with TRizol (Invitrogen) according to the manufacturer's instructions. A first-strand cDNA synthesis reaction was conducted by adding $\documentclass[12pt]{minimal}
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                \begin{document}$$1\,\mu \hbox {g}$$\end{document}$ of total RNA to 500 ng of oligo(dT)15 primer (Promega) and 10 mM deoxynucleotide triphosphates. The mixture was heated for $\documentclass[12pt]{minimal}
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                \begin{document}$$65\,{^{\circ }}\hbox {C}$$\end{document}$ for 5 min and then incubated on ice for 5 min. First-strand buffer (Invitrogen), 0.1 M dithiothreitol and 200 U M-MLV RT (Moloney Murine Leukemia Virus Reverse Transcriptase -- Invitrogen) were then added to a total volume of $\documentclass[12pt]{minimal}
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                \begin{document}$$37\,{^{\circ }}\hbox {C}$$\end{document}$ for 50 min followed by 15 min at $\documentclass[12pt]{minimal}
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                \begin{document}$$70\,{^{\circ }}\hbox {C}$$\end{document}$ for enzyme inactivation. Quantitative PCR (qPCR) assay was performed using 1:5 cDNA as template and Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen) with specific primers (Supplementary Table [S13](#MOESM2){ref-type="media"}) on 7500 Real-Time PCR Systems (Applied Biosystems). The qPCR reactions were carried out at $\documentclass[12pt]{minimal}
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                \begin{document}$$95\,{^{\circ }}\hbox {C}$$\end{document}$ for 10 min followed by 40 cycles of $\documentclass[12pt]{minimal}
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                \begin{document}$$60\,{^{\circ }}\hbox {C}$$\end{document}$ for 1 min. A melting curve analysis was done to verify the specificity of the synthesized products and the amplification efficiency for each primer was calculated with the LinRegPCR software application^[@CR100]^. The mRNA levels were normalized against porcine DNA topoisomerase II beta (*TOP2B*) and the relative expression of mRNA was calculated by $\documentclass[12pt]{minimal}
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                \begin{document}$$2^{-\Delta \Delta {\mathrm{CT}}}$$\end{document}$ method. The threshold cycle (CT) of each target test represents the average of three reactions. Three independent biological replicates were done for each target gene. Statistical analyses were performed using the GraphPad Prism 7.0 software with a two-tailed unpaired t-test to compare the relative expression between infected and non-infected NPTr cells ($\documentclass[12pt]{minimal}
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Computational analysis of sequencing data {#Sec23}
-----------------------------------------

### Preprocessing of raw reads {#Sec24}

The reads from sRNA-seq and total RNA-seq were processed separately. The raw reads were filtered for low quality, and adapter sequences were trimmed with CUTADAPT^[@CR101]^. Total mRNA-seq clean reads were mapped against the porcine reference genome from Ensembl (Sscrofa10.2) with STAR^[@CR102]^ and the raw counts of genes were obtained with HTSeq^[@CR103]^. Only uniquely mapped reads were used for further analyses.

For miRNA prediction, clean sRNA-seq reads were mapped against the porcine genome with Bowtie^[@CR104]^. We used intracellular samples as input for miRDeep2^[@CR76]^ and kept predictions that had a score of at least 5. After this, we collapsed similar predictions and obtained a total of 773 clusters (773 miRNAs), of which 478 were novel miRNAs. We created a porcine miRNA DB (ssc-miRNA-DB), by including the 411 annotated porcine miRNAs in version 21 of miRBase^[@CR77],\ [@CR105]^ along with the 722 miRNAs characterized by Martini et al. (2014)^[@CR78]^ and our novel predictions. Reads from all samples were mapped against this database and a matrix of counts was generated in order to identify DE miRNAs.

### Differential expression of mRNA data {#Sec25}

Raw counts were used as input for DE gene analysis. We detected possible DE genes in both EdgeR^[@CR106]^ and DESeq2^[@CR107]^ packages in R. DESeq2 was run for genes that had a total count of at least 10 in all libraries, with the method's default normalization. EdgeR was used with TMM normalization and general linear model fit, only for genes with cpm greater than 1 in at least 2 libraries. After testing, the adjusted p-values (p-adj) for both methods were adjusted with the Benjamini-Hochberg^[@CR108]^ correction for multitesting. Genes were considered DE when p-adj $\documentclass[12pt]{minimal}
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                \begin{document}$$< 0.05$$\end{document}$ and genes with the most pronounced logFC were selected individually for further investigation. Overall, DESeq2 detected more significant p-adj with less accentuated LogFC, while EdgeR detected less significant false discovery rates (FDR) with more extreme LogFCs. Both techniques have been widely used separately and together in several publications, and in order to select good candidates for testing, we took into account the results of both methods. For GO functional analyses, we also used the complete list of DE genes whenever LogFC was greater than 0.1 (up-regulated) or smaller than $\documentclass[12pt]{minimal}
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                \begin{document}$$-0.1$$\end{document}$ (down-regulated). The complete lists from each method were used separately, and we compared the overall outcomes to check the robustness of our results.

### Differential expression of miRNA data {#Sec26}

The same pipeline used for DE mRNA was performed for total intracellular and total extracellular miRNAs, since we had biological replicates in both cases. In the case where we had no replicates (instead, a single library was constructed from a pool of 50 biological replicates), we used GFOLD^[@CR109]^ which provides a generalized fold change for ranking DE genes. GFOLD is said to overcome the shortcomings of p-value and fold change of the existing methods and can provide a more stable and biological meaningful gene ranking when a single biological replicate is available. In this case, we selected miRNAs with GFOLD $\documentclass[12pt]{minimal}
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                \begin{document}$$< -2$$\end{document}$ for functional analyses.

### miRNA target prediction {#Sec27}

DE miRNAs were used as input to detect putative interactions with the UTRs of Ensembl transcripts in the porcine genome. We used three methods to detect target pairs: miRanda^[@CR110]^, TargetScan^[@CR111]^ and PITA^[@CR112]^, and one method to validate the hybridization of a target pair, RNAhybrid^[@CR113]^. We kept only targets that were predicted by at least two distinct tools and used the following thresholds: score in miRanda $\documentclass[12pt]{minimal}
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                \begin{document}$$< -15$$\end{document}$. Since TargetScan does not provide a continuous scoring system, we only validated whenever there was a prediction of at least 6mers. Based on these, we chose from the target list only genes that were detected as DE in this study, and subsequentially we only considered target pairs of miRNA-mRNA that had inversed LogFC expression.

### Functional analysis of DE mRNAs and targets of DE miRNAs {#Sec28}

Functional analysis took into account as input either the list of DE mRNAs itself or the list of targets predicted for the DE miRNAs. We performed a GO enrichment analysis^[@CR114]^ to find out which functions were over or underrepresented in each gene list. P-values for enriched GO terms were adjusted with the Benjamini-Hochberg^[@CR108]^ correction for multitesting. GO terms and pathways with p-adj $\documentclass[12pt]{minimal}
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                \begin{document}$$< 0.05$$\end{document}$ were defined as significantly enriched. The GO terms were reduced to representative non redundant terms with the use of the REVIGO tool^[@CR115]^.

### Regulatory network reconstruction and analysis {#Sec29}

We created a general regulatory network of the host response to the bacterial infection with the DE miRNAs and target mRNAs detected in this study (Supplementary Fig. [S9](#MOESM1){ref-type="media"} and Supplementary File S1). In this network, we also included information about interactions from the BioGRID v3.4 database^[@CR80],\ [@CR81]^, a general repository that includes experimentally validated physical and genetic interactions. We used human-based official gene symbols to include information from BioGRID, Cytoscape^[@CR116]^ to draw the networks, and the ClueGO plugin^[@CR82]^ to perform functional enrichment analysis. We further manually curated the networks for genes and miRNAs related with redox homeostasis (permissive regulatory network), as well as cytoskeleton and cilia (repressive regulatory network).
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